Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer

SIMPLE SUMMARY: CDK4/6 inhibitors target cell proliferation resulting in toxicity, mainly bone marrow suppression manifesting as neutropenia. Radiation therapy (RT), widely used in breast cancer patients, may enhance myelotoxicity, and no consensus guidelines exist to guide practice when both treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubeczko, Marcin, Gabryś, Dorota, Gawkowska, Marzena, Polakiewicz-Gilowska, Anna, Cortez, Alexander J., Krzywon, Aleksandra, Woźniak, Grzegorz, Latusek, Tomasz, Leśniak, Aleksandra, Świderska, Katarzyna, Mianowska-Malec, Marta, Łanoszka, Barbara, Chomik, Konstanty, Gajek, Mateusz, Michalik, Anna, Nowicka, Elżbieta, Tarnawski, Rafał, Rutkowski, Tomasz, Jarząb, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913652/
https://www.ncbi.nlm.nih.gov/pubmed/36765648
http://dx.doi.org/10.3390/cancers15030690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913652/
https://www.ncbi.nlm.nih.gov/pubmed/36765648
http://dx.doi.org/10.3390/cancers15030690

Ejemplares similares